Acorda Therapeutics reported $30.07M in Selling and Administration Expenses for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 89.9M 6.78M
Acorda Therapeutics ACOR:US $ 30.07M 4.63M
Agios Pharmaceuticals AGIO:US $ 28.26M 3.25M
ALKERMES ALKS:US 150.38M 5.32M
Amgen AMGN:US $ 1.33B 99M
Anika Therapeutics ANIK:US $ 21.27M 2.07M
Arrowhead Research ARWR:US $ 32.74M 1.12M
Biogen BIIB:US $ 572.6M 62.3M
Biomarin Pharmaceutical BMRN:US $ 196.83M 2.22M
Cara Therapeutics CARA:US $ 7.54M 1.78M
Clovis Oncology CLVS:US $ 32.59M 3.38M
Cytokinetics CYTK:US $ 42.72M 9.65M
Enanta Pharmaceuticals ENTA:US $ 12.93M 2.45M
Gilead Sciences GILD:US $ 1.36B 274M
GlaxoSmithKline GSK:LN 1.96B 726M
Halozyme Therapeutics HALO:US $ 57.48M 43.64M
Heron Therapeutics HRTX:US $ 32.12M 836K
Insmed INSM:US $ 59.97M 3.23M
Ligand Pharmaceuticals LGND:US $ 29.17M 10.99M
Mannkind MNKD:US $ 26.04M 5.35M
Merck MRK:GR 1.52B 151M
Moderna Inc MRNA:US 211M 57M
Neurocrine Biosciences NBIX:US $ 182.8M 17.9M
Novartis NOVN:VX 3.59B 91M
Pfizer PFE:US $ 3.2B 506M
Teva Pharmaceutical TEVA:IT 849M 30M
Ultragenyx Pharmaceutical RARE:US $ 68.14M 825K
Vertex Pharmaceuticals VRTX:US $ 215.3M 100K